Luca Issi
Stock Analyst at RBC Capital
(3.73)
# 870
Out of 5,140 analysts
218
Total ratings
49.64%
Success rate
8.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Maintains: Outperform | $245 → $250 | $219.95 | +13.66% | 4 | Jan 20, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $500 → $465 | $376.00 | +23.67% | 29 | Jan 20, 2026 | |
| ARGX argenx SE | Maintains: Outperform | $860 → $925 | $820.00 | +12.80% | 3 | Dec 17, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Outperform | $82 → $95 | $82.00 | +15.85% | 11 | Dec 17, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Outperform | $52 → $80 | $70.89 | +12.85% | 11 | Dec 11, 2025 | |
| WVE Wave Life Sciences | Upgrades: Outperform | $9 → $27 | $14.44 | +86.98% | 6 | Dec 9, 2025 | |
| FULC Fulcrum Therapeutics | Maintains: Sector Perform | $7 → $10 | $11.00 | -9.09% | 3 | Dec 8, 2025 | |
| MRNA Moderna | Maintains: Sector Perform | $28 → $25 | $54.86 | -54.43% | 18 | Nov 21, 2025 | |
| AGIO Agios Pharmaceuticals | Downgrades: Sector Perform | $57 → $28 | $28.67 | -2.34% | 1 | Nov 20, 2025 | |
| KRRO Korro Bio | Downgrades: Sector Perform | $85 → $8 | $10.45 | -23.44% | 8 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $42 → $50 | $59.79 | -16.37% | 15 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $19 | $15.95 | +19.12% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $14 → $9 | $15.25 | -40.98% | 7 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $30 | $18.09 | +65.84% | 4 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $45 | $22.71 | +98.15% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $61 → $72 | $72.66 | -0.91% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $1.72 | +481.40% | 9 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $18 | $21.91 | -17.85% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $20 | $7.76 | +157.90% | 5 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $2 | $0.40 | +401.50% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $17 | $11.49 | +47.95% | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $13 | $8.09 | +60.69% | 6 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $35 | $8.15 | +329.71% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $26 | $33.52 | -22.43% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $58.16 | +20.36% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $57 | $49.11 | +16.07% | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $2.36 | +69.85% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $77 | $23.73 | +224.48% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $1.64 | +753.66% | 5 | Aug 7, 2024 |
Ascendis Pharma
Jan 20, 2026
Maintains: Outperform
Price Target: $245 → $250
Current: $219.95
Upside: +13.66%
Alnylam Pharmaceuticals
Jan 20, 2026
Maintains: Outperform
Price Target: $500 → $465
Current: $376.00
Upside: +23.67%
argenx SE
Dec 17, 2025
Maintains: Outperform
Price Target: $860 → $925
Current: $820.00
Upside: +12.80%
Ionis Pharmaceuticals
Dec 17, 2025
Maintains: Outperform
Price Target: $82 → $95
Current: $82.00
Upside: +15.85%
Arrowhead Pharmaceuticals
Dec 11, 2025
Maintains: Outperform
Price Target: $52 → $80
Current: $70.89
Upside: +12.85%
Wave Life Sciences
Dec 9, 2025
Upgrades: Outperform
Price Target: $9 → $27
Current: $14.44
Upside: +86.98%
Fulcrum Therapeutics
Dec 8, 2025
Maintains: Sector Perform
Price Target: $7 → $10
Current: $11.00
Upside: -9.09%
Moderna
Nov 21, 2025
Maintains: Sector Perform
Price Target: $28 → $25
Current: $54.86
Upside: -54.43%
Agios Pharmaceuticals
Nov 20, 2025
Downgrades: Sector Perform
Price Target: $57 → $28
Current: $28.67
Upside: -2.34%
Korro Bio
Nov 13, 2025
Downgrades: Sector Perform
Price Target: $85 → $8
Current: $10.45
Upside: -23.44%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $42 → $50
Current: $59.79
Upside: -16.37%
Nov 7, 2025
Maintains: Outperform
Price Target: $17 → $19
Current: $15.95
Upside: +19.12%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $14 → $9
Current: $15.25
Upside: -40.98%
Nov 6, 2025
Maintains: Outperform
Price Target: $23 → $30
Current: $18.09
Upside: +65.84%
Nov 4, 2025
Maintains: Outperform
Price Target: $65 → $45
Current: $22.71
Upside: +98.15%
Oct 28, 2025
Downgrades: Sector Perform
Price Target: $61 → $72
Current: $72.66
Upside: -0.91%
May 14, 2025
Reiterates: Outperform
Price Target: $10
Current: $1.72
Upside: +481.40%
May 8, 2025
Maintains: Sector Perform
Price Target: $21 → $18
Current: $21.91
Upside: -17.85%
Mar 25, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $7.76
Upside: +157.90%
Mar 18, 2025
Reiterates: Sector Perform
Price Target: $2
Current: $0.40
Upside: +401.50%
Mar 18, 2025
Initiates: Outperform
Price Target: $17
Current: $11.49
Upside: +47.95%
Mar 17, 2025
Maintains: Outperform
Price Target: $11 → $13
Current: $8.09
Upside: +60.69%
Mar 3, 2025
Maintains: Outperform
Price Target: $39 → $35
Current: $8.15
Upside: +329.71%
Feb 26, 2025
Maintains: Sector Perform
Price Target: $24 → $26
Current: $33.52
Upside: -22.43%
Feb 20, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $58.16
Upside: +20.36%
Jan 21, 2025
Reiterates: Outperform
Price Target: $57
Current: $49.11
Upside: +16.07%
Dec 13, 2024
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.36
Upside: +69.85%
Nov 6, 2024
Reiterates: Outperform
Price Target: $77
Current: $23.73
Upside: +224.48%
Aug 7, 2024
Reiterates: Outperform
Price Target: $14
Current: $1.64
Upside: +753.66%